EIR Stason Pharmaceuticals Jul 2000

Ryan Borges FDA, Terri Dodds FDA, Katherine Jacobitz FDA$595.00 - Available Now

FDA investigators audited the Stason Pharmaceuticals - Irvine, CA, United States facility and issued inspectional observation (via FDA 483) on 28 Jul 2000.

Product details

  • Category:
  • Inspection end: 28 Jul 2000
  • Location: Irvine, United States
  • FEI: 1000160561
Add To Cart